ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

DFA Proposes Controversial Guidelines For Clinical Tests

November 21, 1975

NCAB forms subcommittee to develop NCI biomedical technologies initiative.

September 26, 2003

NCI-Approved Clinical Trials

October 29, 2004

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

January 3, 1992

IOM Panel Considering NCI Approach To Research In Minorities, Underserved

June 19, 1998

NCI-Approved Trials Listed

April 28, 2006